8-KThe WireRed Alert
Executive Change · Shareholder Vote
Filed Jun 8, 2023 · 3y ago · Accession 0001517022-23-000014
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Akebia Therapeutics, Inc.
- Ticker
- AKBA
- CIK
- 1517022
- Form type
- 8-K
- Filing date
- Jun 8, 2023
- Report date
- Jun 6, 2023
- Document
- akba-20230606.htm
- Size
- 207 KB